newsfilter
← Latest News
PR Newswire·

EMA Grants Accelerated Assessment for CSL Behring's Haemophilia B Gene Therapy

MARBURG, Germany, Dec. 15, 2021 /PRNewswire/ -- CSL Behring today announced that the European Medicines Agency (EMA) has granted its approval for an accelerated assessment request for etranacogene dezaparvovec Marketing Authorisation Application (MAA).